These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22130579)

  • 1. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.
    Zheng JM; Yao GH; Cheng Z; Wang R; Liu ZH
    Diabetologia; 2012 Mar; 55(3):801-11. PubMed ID: 22130579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells in human allografted kidney: correlation with interstitial fibrosis.
    Goto E; Honjo S; Yamashita H; Shomori K; Adachi H; Ito H
    Clin Transplant; 2002; 16 Suppl 8():7-11. PubMed ID: 12464125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis.
    Okoń K; Stachura J
    Pol J Pathol; 2007; 58(3):193-7. PubMed ID: 18074865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?
    Balakumar P; Reddy J; Singh M
    Mol Cell Biochem; 2009 Oct; 330(1-2):187-92. PubMed ID: 19415459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells and type VIII collagen in human diabetic nephropathy.
    Rüger BM; Hasan Q; Greenhill NS; Davis PF; Dunbar PR; Neale TJ
    Diabetologia; 1996 Oct; 39(10):1215-22. PubMed ID: 8897010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.
    Wang M; Xie R; Liu R; Jia X; Bao Y; Liu X
    Endocrine; 2012 Oct; 42(2):329-34. PubMed ID: 22396142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells: the forgotten cells of renal fibrosis.
    Roberts IS; Brenchley PE
    J Clin Pathol; 2000 Nov; 53(11):858-62. PubMed ID: 11127270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
    Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased chymase-positive mast cells in children with crescentic glomerulonephritis.
    Togawa H; Nakanishi K; Shima Y; Obana M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2009 May; 24(5):1071-5. PubMed ID: 19050935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Thomas MC; Hurst LA; Tesch GH
    Diabetologia; 2009 Aug; 52(8):1669-79. PubMed ID: 19466391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.
    Beghdadi W; Madjene LC; Claver J; Pejler G; Beaudoin L; Lehuen A; Daugas E; Blank U
    Kidney Int; 2013 Aug; 84(2):317-26. PubMed ID: 23515052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell infiltration is involved in renal interstitial fibrosis in a rat model of protein-overload nephropathy.
    Li Y; Zhou L; Liu F; Peng Y; Li J; Sun L; Duan S; Ling G; Chen X; Jiang W; Xia Y
    Kidney Blood Press Res; 2010; 33(3):240-8. PubMed ID: 20606473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.
    Shimbori C; Upagupta C; Bellaye PS; Ayaub EA; Sato S; Yanagihara T; Zhou Q; Ognjanovic A; Ask K; Gauldie J; Forsythe P; Kolb MRJ
    Thorax; 2019 May; 74(5):455-465. PubMed ID: 30808717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury.
    Fan Z; Gao Y; Jiang N; Zhang F; Liu S; Li Q
    Front Immunol; 2022; 13():979995. PubMed ID: 36304455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.